White Paper
Expert Q&A: What Utah’s AI Prescription Renewal Pilot Signals About the Evolving Role of AI in Treatment Decisions
White Paper Summary
At the start of 2026, the Utah Department of Commerce’s Office of Artificial Intelligence Policy announced a partnership with Doctronic to allow an AI system to legally renew certain prescriptions for patients with chronic health conditions.
The pilot presents a ground-breaking use case for AI in healthcare that can deliver potential benefits – assuming the right guardrails are in place. Utah’s approach reflects a proactive effort to explore how emerging technologies can help address access gaps, reduce friction in care, and test new models under controlled conditions.
The pilot program also raises some questions – which is why we sat down with Sandy Shtab, Healthesystems VP of Industry and State Affairs, and Silvia Sacalis, VP of Clinical Services, to discuss the role of AI in treatment decisions and what needs to be considered in its governance.
For more content like this from Healthesystems visit their RxInformer clinical journal website.



